earli
report
classifi
case
sar
basi
clinic
case
definit
although
recognit
sarscov
caus
agent
allow
specif
laboratori
confirm
made
approxim
patient
present
sar
laboratoryconfirm
sarscov
infect
remaind
either
infecti
caus
sever
atyp
pneumonia
undetect
sarscov
infect
among
clinic
laboratori
featur
sar
number
hematolog
abnorm
describ
promin
amongst
total
lymphopenia
although
studi
lymphocyt
subset
analys
report
studi
examin
lymphocyt
subset
undertaken
cohort
laboratoryconfirm
case
sar
daili
clinic
laboratori
find
sar
patient
ditan
hospit
beij
enter
predesign
databas
clinic
case
definit
probabl
sar
includ
fever
higher
cough
short
breath
new
pulmonari
infiltr
chest
radiographi
close
contact
person
suspect
probabl
case
sar
day
ill
defin
day
onset
fever
blood
collect
sarscov
specif
antibodi
test
patient
hospit
sarscov
specif
igm
igg
detect
use
indirect
immunofluoresc
assay
ifa
euroimmun
ag
lubeck
germani
sarscov
rna
detect
throat
wash
stool
blood
use
sarscov
rna
fluoresc
quantit
rtpcr
assay
shenzhen
pj
compani
shenzhen
guangdong
provinc
china
immunolog
test
includ
nk
b
lymphocyt
cell
count
flow
cytometri
multitest
trucount
fourcolor
kit
multitest
trucount
fourcolor
kit
bd
bioscienc
san
jose
ca
usa
lymphocyt
count
perform
control
nonsarsaffect
otherwis
healthi
individu
analys
perform
singl
laboratori
studi
approv
ethic
committe
ditan
hospit
beij
china
patient
satisfi
case
definit
probabl
sar
retrospect
classifi
discharg
nonsever
sever
case
nonsever
sever
group
defin
accord
standard
clinic
diagnosi
atyp
pneumonia
guidelin
list
chines
public
health
ministri
may
patient
nonsever
group
fever
higher
cough
short
breath
new
pulmonari
infiltr
chest
radiographi
patient
sever
group
addit
least
one
follow
featur
dyspnea
respiratori
rate
minut
hypoxemia
pao
mmhg
spo
whilst
oxygen
rate
lminut
acut
lung
injuryacut
respiratori
distress
syndrom
chest
radiograph
show
multifoc
involv
one
third
lung
field
develop
hour
shock
multipl
organ
dysfunct
syndrom
mod
also
underli
diseas
develop
secondari
infect
year
old
patient
satisfi
case
definit
probabl
sar
retrospect
classifi
discharg
recov
case
die
sar
probabl
sar
patient
regard
laboratori
confirm
least
one
follow
sarscov
igg
andor
igm
antibodi
detect
ifa
three
week
onset
ill
andor
sarscov
rna
detect
rtpcr
first
two
week
ill
studi
patient
laboratori
confirm
sar
includ
sarscov
detect
rtpcr
respiratori
tract
fecal
sampl
sarscov
rtpcr
posit
sampl
sarscov
igg
detect
sarscov
igm
use
ifa
neg
sar
test
altern
laboratori
diagnosi
made
common
acut
influenza
b
case
klebsiella
pneumonia
infect
nine
case
mean
age
laboratoryconfirm
sar
case
ae
year
year
age
nine
year
femal
male
health
care
worker
includ
nurs
physician
other
cohort
thirtytwo
patient
underli
health
problem
includ
diabet
case
cardiac
diseas
eight
case
malign
four
case
chronic
airway
diseas
one
case
chronic
renal
failur
one
case
one
hundr
twelv
individu
acquir
sar
hospit
set
health
care
worker
inpati
visitor
mostli
ward
hospit
case
infect
follow
home
exposur
famili
member
friend
hospitalassoci
case
come
close
contact
affect
individu
lymphocyt
subpopul
count
compar
sampl
collect
case
laboratoryconfirm
sar
patient
control
tabl
total
lymphocyt
count
sar
patient
compar
normal
individu
lymphocyt
count
week
onset
ill
compar
week
ill
normal
individu
use
nonparametr
test
signific
decreas
count
five
week
sar
ill
compar
healthi
control
although
ratio
chang
significantli
cours
ill
variou
lymphocyt
popul
normal
rang
first
week
clinic
ill
reach
nadir
second
week
return
toward
normal
level
signific
differ
lymphocyt
subset
count
week
week
week
week
tabl
figur
observ
defin
tabl
count
sampl
collect
daili
first
day
sar
list
total
lymphopenia
mark
day
second
week
ill
tabl
lymphocyt
subpopul
count
compar
sever
sar
sampl
patient
nonsever
sar
sampl
patient
recov
sampl
case
die
sampl
patient
sar
count
significantli
lower
use
nonparametr
test
patient
die
compar
recov
sever
diseas
compar
nonsever
diseas
interact
sarscov
immun
system
complex
studi
lymphocyt
subset
measur
five
week
effect
sever
acut
respiratori
syndrom
sar
coronaviru
infect
figur
kinet
lymphocyt
subset
express
mean
number
cell
l
measur
first
five
week
ill
nonsever
sever
laboratoryconfirm
sar
patient
otherwis
healthi
control
laboratoryproven
nonsever
sever
case
sar
patient
either
recov
die
total
lymphocyt
count
decreas
first
two
week
ill
nadir
week
increas
third
week
return
normal
level
fifth
week
peripher
blood
lymphocyt
subset
quantit
dynam
method
larg
cohort
laboratoryproven
case
sar
studi
confirm
observ
lymphopenia
note
seri
sar
case
studi
hong
kong
report
absolut
lymphopenia
l
patient
cours
ill
mark
second
week
data
discuss
extend
observ
provid
first
data
mainland
china
show
total
lymphocyt
count
sar
patient
lower
normal
individu
throughout
clinic
cours
mark
sever
diseas
compar
less
sever
ill
die
compar
survivor
studi
patient
amoy
garden
outbreak
hong
kong
find
associ
total
lymphocyt
count
progress
ventilatori
support
intens
care
although
differ
progress
acut
respiratori
distress
syndrom
ard
oxygen
satur
gastrointestin
symptom
two
cohort
howev
associ
lymphopenia
sever
diseas
seen
anoth
cohort
sar
case
hong
kong
contrast
seri
adult
sar
case
studi
report
patient
laboratori
evid
sarscov
infect
two
seri
total
children
probabl
suspect
sar
although
four
children
laboratoryproven
sar
total
lymphopenia
common
promin
older
children
sever
diseas
lymphocyt
subset
also
count
patient
signific
cell
lymphopenia
observ
first
two
week
sar
ill
patient
studi
prolong
lymphopenia
note
cell
fell
approxim
one
half
second
week
ill
return
near
normal
end
week
addit
patient
sever
diseas
lower
count
took
longer
rise
data
show
count
lower
sever
ill
patient
die
ratio
significantli
differ
variou
patient
group
b
lymphocyt
first
lymphocyt
numer
recov
two
week
recoveri
associ
appear
sarscov
specif
igg
igm
nk
cell
also
began
decreas
first
week
although
rise
nk
cell
toward
end
week
lowest
level
week
return
normal
week
lymphopenia
promin
part
sarscov
infect
lymphocyt
count
may
use
predict
sever
clinic
outcom
total
subset
lymphopenia
occur
acut
eg
measl
cytomegaloviru
chronic
eg
hiv
viral
infect
human
anim
lymphopenia
featur
human
coronaviru
infect
adult
lymphopenia
describ
case
experiment
coronaviru
infect
human
possibl
reason
lymphopenia
may
lymphocyt
directli
infect
destroy
sarscov
howev
angiotensinconvert
enzym
identifi
function
cellular
receptor
sarscov
protein
express
b
lymphocyt
would
suggest
direct
viral
invas
destruct
lymphocyt
major
caus
acut
lymphopenia
sar
requir
studi
possibl
explan
lymphopenia
lymphocyt
sequestr
lung
sarscov
damag
evid
cytokinemedi
alter
lymphocyt
traffick
may
immunemedi
lymphocyt
destruct
lymphocyt
deplet
note
autopsi
lymph
node
sar
case
bone
marrow
thymu
suppress
apoptosi
apoptosi
observ
vitro
measlesinduc
lymphopenia
coronaviru
caus
vitro
apoptosi
monocytesmacrophag
whether
differ
strain
sarscov
variabl
effect
immun
respons
clinic
diseas
occur
experiment
measl
macaqu
unknown
possibl
sarscovinduc
immun
suppress
predispos
secondari
infect
especi
sever
ill
patient
unknown
longer
term
effect
humor
cellmedi
immun
follow
sar
conflict
interest
conflict
interest
declar
